
Brazil: best selling medications 2017, by sales revenue
In 2017, muscle relaxant Dorflex was the best-selling medication in Brazil, with a sales revenue of 470.4 million Brazilian reals. The second position was occupied by Xarelto, an anticoagulant medicine to treat venous thrombosis, with a sales revenue of nearly 287 million reals that year.